Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cognition
Biotech
Neurocrine's bid to save schizophrenia prospect fails
The biotech was unable to replicate the cognition signal it saw in an earlier midphase study, prompting it to stop development of luvadaxistat.
Nick Paul Taylor
Sep 13, 2024 7:30am
Sage fails first of 4 tests for key prospect, exits Parkinson's
Apr 17, 2024 8:34am
Penumbra launches VR-based full body rehab system
Nov 16, 2022 11:54am
Savonix picks up an extra $9.6M for its cognition test app
Apr 29, 2019 8:15am
NeuroServo's portable EEG could help detect delirium
Apr 5, 2019 10:15am
